Aurobindo receives final FDA OK for stavudine
This article was originally published in Scrip
Executive Summary
Aurobindo Pharmahas received final US FDAapproval for stavudine capsules 15mg, 20mg, 30mg and 40mg and stavudine oral solution 1mg/ml, generic versions of Bristol-Myers Squibb's antiretroviral, Zerit. Aurobindo now has 63 final and 24 tentative ANDA approvals from the US FDA.